# Cagent Vascular

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cagent-vascular

- Industry: Medical Devices & Equipment
- Headquarters: Wayne, US
- Website: www.cagentvascular.com
- Total disclosed funding: $67M
- Latest round: Series D (May 18, 2026)
- Investors on record: 8

## About

Founded in 2014 and based in Pennsylvania, US, Cagent Vascular, LLC is a commercial-stage medical device company. The company was founded by its CMO, Peter Schneider, and CTO, Robert Giasolli.  In May 2026, Cagent Vascular, Inc. raised USD 41 million in series D funding co-led by Astoria Health Investors and US Venture Partners. As of 2024, the company is led by its CEO, Brian Walsh.

Cagent Vascular designs and develops medical devices for treating cardiovascular disease. The company's main product is the Serranator PTA Serration Balloon Catheter, which is a device designed for treating patients suffering from peripheral arterial disease (PAD). The company will use the May 2026 funding to support clinical trials, global commercialization, and development of its coronary artery platform.

## Funding rounds

- Series D, May 18, 2026, $24M — US Venture Partners, Astoria Health Investors
- Series C, Feb 20, 2024, $30M — Venture Partners, Blue Ridge Medical Inc., Sectoral Asset Management
- Series B, Jul 12, 2018, $12M — Ben Franklin Technology Partners, Synergy Ventures, Balestier Investments
- Seed, Jun 22, 2016, $0.5M — Ben Franklin Technology Partners

## Investors

- Ben Franklin Technology Partners (https://capitalatlas.ai/funds/ben-franklin-technology-partners) — Seed, Series B
- Synergy Ventures (https://capitalatlas.ai/funds/synergy-ventures) — Series B
- Balestier Investments — Series B
- Venture Partners (https://capitalatlas.ai/funds/venture-partners) — Series C
- Blue Ridge Medical Inc. — Series C
- Sectoral Asset Management (https://capitalatlas.ai/funds/sectoral-asset-management) — Series C
- US Venture Partners (https://capitalatlas.ai/funds/us-venture-partners) — Series D
- Astoria Health Investors (https://capitalatlas.ai/funds/astoria-health-investors) — Series D